Reaction

Vulvovaginal Mycotic Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,873 reports · 81 co-occurring drugs

As of the last recalculation, Vulvovaginal Mycotic Infection appears in 3,873 FAERS reports alongside 81 co-occurring drug terms. The strongest observed disproportionality signal is CANAGLIFLOZIN (PRR 23.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Canagliflozin	125	23.2	23.3
Etonogestrel And Ethinyl Estradiol	83	20.5	20.6
Estradiol	242	16.0	16.0
Miconazole Nitrate	25	15.5	15.5
Quinine	23	14.5	14.5
Empagliflozin	173	14.4	14.4
Terazosin Hydrochloride	23	14.0	14.0
Conjugated Estrogens	130	12.4	12.4
Estrogens, Conjugated	130	12.1	12.2
Bimekizumab	42	10.7	10.7
Dimenhydrinate	21	10.6	10.7
Alemtuzumab	36	10.1	10.1
Epoetin Alfa	22	10.0	10.0
Linagliptin	31	9.2	9.2
Fluconazole	101	7.9	7.9
Levonorgestrel	253	7.2	7.2
Infliximab-Dyyb	38	7.0	7.1
Copper	53	6.7	6.7
Baricitinib	11	6.1	6.2
Clotrimazole	14	6.1	6.2
Desloratadine	12	6.0	6.0
Drospirenone And Ethinyl Estradiol	48	5.9	5.9
Chlorhexidine Gluconate	10	5.9	5.9
Estradiol Gel 0.1%	47	5.6	5.7
Estradiol Transdermal	47	5.6	5.6
Drs. Clotrimazole	12	5.6	5.6
Family Wellness Clotrimazole	12	5.6	5.6
Clotrimazole Topical	12	5.6	5.6
Ocrelizumab	63	5.5	5.5
Amoxicillin And Clavulanate Potassium	27	5.4	5.4
Nitrofurantoin	15	4.9	4.9
Clindamycin Phosphate	30	4.9	4.9
Nitrofurantoin (Monohydrate/Macrocrystals)	15	4.8	4.8
Clindamycin	23	4.4	4.4
Ixazomib	23	4.3	4.3
Conjugated Estrogens And Medroxyprogesterone Acetate	18	4.1	4.1
Adrenalinum	30	3.9	3.9
Loperamide Hydrochloride And Dimethicone	23	3.9	3.9
Baclofen	61	3.9	3.9
Progesterone	16	3.8	3.8
Fexofenadine	11	3.6	3.6
Thyroid, Porcine	7	3.5	3.5
Etanercept	367	3.5	3.5
Aprepitant	12	3.5	3.5
Oxybutynin	18	3.3	3.3
Tofacitinib Citrate	8	3.3	3.3
Linaclotide	16	3.2	3.2
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	21	3.2	3.2
Certolizumab Pegol	69	3.2	3.2
Fosaprepitant Dimeglumine	8	3.1	3.1
Sitagliptin And Metformin Hydrochloride	12	3.0	3.0
Sumatriptan	21	3.0	3.0
Ixekizumab	20	2.9	2.9
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	22	2.9	2.9
Vortioxetine	9	2.8	2.8
Desoximetasone	10	2.8	2.8
Rocuronium Bromide	6	2.7	2.7
Sevoflurane	4	2.6	2.6
Fingolimod Hcl	41	2.6	2.6
Rimegepant Sulfate	6	2.5	2.5
Bosutinib	4	2.4	2.4
Vilazodone Hydrochloride	4	2.3	2.3
Secukinumab	66	2.2	2.2
Liraglutide	20	2.2	2.2
Rifaximin	8	2.1	2.1
Oral Semaglutide	27	2.0	2.0
Ofatumumab	12	1.9	1.9
Ustekinumab	36	1.9	1.9
Peginterferon Alfa-2A	19	1.9	1.9
Natalizumab	59	1.8	1.8
Atezolizumab	12	1.7	1.7
Dulaglutide	26	1.6	1.6
Pseudoephedrine Hydrochloride	3	1.6	1.6
Alirocumab	7	1.5	1.5
Pseudoephedrine Hcl	3	1.5	1.5
Exenatide	14	1.4	1.4
Sarilumab	7	1.4	1.4
Isotretinoin	13	1.4	1.4
Dalfampridine	18	1.4	1.4
Dimethyl Fumarate	28	1.2	1.2
Etonogestrel	10	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.